Mirati Therapeutics, Inc. (MRTX): Price and Financial Metrics

Mirati Therapeutics, Inc. (MRTX): $37.92

0.91 (+2.46%)

POWR Rating

Component Grades








Add MRTX to Watchlist
Sign Up

Industry: Biotech




#260 of 380

in industry

MRTX Price/Volume Stats

Current price $37.92 52-week high $101.30
Prev. close $37.01 52-week low $35.70
Day low $36.85 Volume 757,086
Day high $38.08 Avg. volume 1,099,104
50-day MA $41.97 Dividend yield N/A
200-day MA $55.82 Market Cap 2.21B

MRTX Stock Price Chart Interactive Chart >


  • Growth is the dimension where MRTX ranks best; there it ranks ahead of 53.01% of US stocks.
  • MRTX's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • MRTX ranks lowest in Stability; there it ranks in the 5th percentile.

MRTX Stock Summary

  • MIRATI THERAPEUTICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.81% of US listed stocks.
  • With a price/sales ratio of 135.01, MIRATI THERAPEUTICS INC has a higher such ratio than 97.86% of stocks in our set.
  • Revenue growth over the past 12 months for MIRATI THERAPEUTICS INC comes in at -74.05%, a number that bests only 2.66% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to MRTX, based on their financial statements, market capitalization, and price volatility, are STOK, PLRX, ORMP, SYNA, and BCYC.
  • Visit MRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.mirati.com.

MRTX Valuation Summary

  • MRTX's price/sales ratio is 140.7; this is 6295.45% higher than that of the median Healthcare stock.
  • MRTX's price/sales ratio has moved NA NA over the prior 120 months.

Below are key valuation metrics over time for MRTX.

Stock Date P/S P/B P/E EV/EBIT
MRTX 2023-05-23 140.7 3.1 -3.6 -3.3
MRTX 2023-05-22 141.4 3.1 -3.6 -3.4
MRTX 2023-05-19 139.1 3.0 -3.6 -3.3
MRTX 2023-05-18 137.9 3.0 -3.5 -3.3
MRTX 2023-05-17 143.1 3.1 -3.7 -3.4
MRTX 2023-05-16 146.8 3.2 -3.8 -3.5

MRTX Growth Metrics

    Its 4 year price growth rate is now at 2178.05%.
  • Its 3 year revenue growth rate is now at 1447.97%.
  • Its 3 year price growth rate is now at 4.18%.
Over the past 33 months, MRTX's revenue has gone up $8,466,000.

The table below shows MRTX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 11.801 -579.755 -738.012
2022-06-30 78.163 -488.978 -644.505
2022-03-31 72.801 -438.853 -634.49
2021-12-31 72.092 -388.8 -581.784
2021-09-30 73.501 -327.236 -483.251
2021-06-30 13.132 -356.967 -490.533

MRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRTX has a Quality Grade of D, ranking ahead of 13.91% of graded US stocks.
  • MRTX's asset turnover comes in at 0.011 -- ranking 387th of 682 Pharmaceutical Products stocks.
  • CYRX, LUMO, and BDSI are the stocks whose asset turnover ratios are most correlated with MRTX.

The table below shows MRTX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.011 1 -0.668
2021-03-31 0.013 1 -0.658
2020-12-31 0.015 1 -0.750
2020-09-30 0.020 1 -0.781
2020-06-30 0.003 1 -0.737
2020-03-31 0.004 1 -0.765

MRTX Price Target

For more insight on analysts targets of MRTX, see our MRTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $216.18 Average Broker Recommendation 1.56 (Moderate Buy)

Mirati Therapeutics, Inc. (MRTX) Company Bio

Mirati Therapeutics develops molecularly targeted cancer treatments that are intended to inhibit tumor growth. The company was founded in 1995 and is based in San Diego, California.

MRTX Latest News Stream

Event/Time News Detail
Loading, please wait...

MRTX Latest Social Stream

Loading social stream, please wait...

View Full MRTX Social Stream

Latest MRTX News From Around the Web

Below are the latest news stories about MIRATI THERAPEUTICS INC that investors may wish to consider to help them evaluate MRTX as an investment opportunity.

Growth Investors: Industry Analysts Just Upgraded Their Mirati Therapeutics, Inc. (NASDAQ:MRTX) Revenue Forecasts By 23%

Shareholders in Mirati Therapeutics, Inc. ( NASDAQ:MRTX ) may be thrilled to learn that the analysts have just...

Yahoo | May 14, 2023

Mirati Therapeutics First Quarter 2023 Earnings: Beats Expectations

Mirati Therapeutics ( NASDAQ:MRTX ) First Quarter 2023 Results Key Financial Results Revenue: US$7.17m (up by US$6.46m...

Yahoo | May 11, 2023

Mirati (MRTX) Q1 Earnings & Revenues Beat Estimates, Stock Up

Mirati (MRTX) reports better-than-expected first-quarter results, wherein earnings and revenues beat estimates. The stock climbs 2% on Tuesday. Pipeline development is on track.

Yahoo | May 10, 2023

Mirati Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Updates

Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the first quarter 2023 along with recent pipeline and corporate updates.

Yahoo | May 9, 2023

Mirati Therapeutics and Sarah Cannon Research Institute Announce Strategic, Community Site Focused Partnership to Increase Diversity in Oncology Clinical Studies

Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, and Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations conducting community-based clinical trials, today announced a strategic partnership aimed at increasing diversity in clinical study recruitment practices.

Yahoo | May 8, 2023

Read More 'MRTX' Stories Here

MRTX Price Returns

1-mo -16.18%
3-mo -12.45%
6-mo -60.60%
1-year -5.81%
3-year -62.26%
5-year -10.57%
YTD -16.31%
2022 -69.11%
2021 -33.21%
2020 70.45%
2019 203.77%
2018 132.44%

Continue Researching MRTX

Want to see what other sources are saying about Mirati Therapeutics Inc's financials and stock price? Try the links below:

Mirati Therapeutics Inc (MRTX) Stock Price | Nasdaq
Mirati Therapeutics Inc (MRTX) Stock Quote, History and News - Yahoo Finance
Mirati Therapeutics Inc (MRTX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!